Drug Type Synthetic peptide |
Synonyms RUFI |
Mechanism ATP-dependent protease ATP-binding subunit ClpC1 inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mycobacterium Abscessus Infection | Preclinical | US | - | |
Mycobacterium Tuberculosis, Susceptibility to Infection By | Preclinical | US | - |